Evidence map›Paper›PMID 41214697›Full record

ArticleCardiovascular diabetology2025

Artificial intelligence identifies individuals with prediabetes using single-lead electrocardiograms.

Daisuke Koga, Ryo Kaneda, Chikara Komiya, Satoshi Ohno, Akira Takeuchi, Kazunari Hara, Masato Horino, Jun Aoki, Rei Okazaki, Ryoko Ishii and 6 more

Abstract readValidation Study
In one paragraph

Article in Cardiovascular diabetology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Daisuke Koga *Department of AI Systems Medicine, M&D Data Science Center, Institute of Integrated Research, Institute of Science Tokyo, Tokyo, 113-8510, Japan.
Ryo Kaneda *Department of Molecular Endocrinology and Metabolism, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, 113-8510, Japan.
Chikara Komiya *Department of Molecular Endocrinology and Metabolism, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, 113-8510, Japan. komiya.mem@tmd.ac.jp.
Satoshi OhnoDepartment of AI Systems Medicine, M&D Data Science Center, Institute of Integrated Research, Institute of Science Tokyo, Tokyo, 113-8510, Japan.
Akira TakeuchiDepartment of Molecular Endocrinology and Metabolism, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, 113-8510, Japan.
Kazunari HaraDepartment of Molecular Endocrinology and Metabolism, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, 113-8510, Japan.
Masato HorinoDepartment of Molecular Endocrinology and Metabolism, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, 113-8510, Japan.
Jun AokiDepartment of Molecular Endocrinology and Metabolism, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, 113-8510, Japan.
Rei OkazakiDepartment of Molecular Endocrinology and Metabolism, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, 113-8510, Japan.
Ryoko IshiiDepartment of Molecular Endocrinology and Metabolism, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, 113-8510, Japan.
Masanori MurakamiDepartment of Molecular Endocrinology and Metabolism, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, 113-8510, Japan.
Kazutaka TsujimotoDepartment of Molecular Endocrinology and Metabolism, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, 113-8510, Japan.
Kenji IkedaDepartment of Molecular Endocrinology and Metabolism, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, 113-8510, Japan.
Hideki KatagiriDepartment of Diabetes, Metabolism and Endocrinology, Tohoku University Graduate School of Medicine, Sendai, 980-8575, Japan.
Hideyuki ShimizuDepartment of AI Systems Medicine, M&D Data Science Center, Institute of Integrated Research, Institute of Science Tokyo, Tokyo, 113-8510, Japan. h_shimizu.dsc@tmd.ac.jp.
Tetsuya YamadaDepartment of Molecular Endocrinology and Metabolism, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, 113-8510, Japan.

Funding

Moonshot Research and Development Program JPMJMS2023
6 · The paper itself

Abstract

backgroundEarly detection of prediabetes is crucial for diabetes prevention, yet it remains challenging due to its asymptomatic nature and low screening rates. This study aimed to develop and rigorously validate artificial intelligence (AI) models to identify individuals with prediabetes solely using electrocardiograms (ECGs).

methodsWe defined prediabetes/diabetes based on fasting plasma glucose ≥ 110 mg/dL, hemoglobin A

resultsThe best-performing model, a LightGBM-based algorithm we termed DiaCardia, achieved an area under the receiver operating characteristic curve (AUROC) of 0.851 in the internal test dataset (sensitivity: 85.7%, specificity: 70.0%). The model demonstrated robust generalizability, achieving an AUROC of 0.785 in the external validation cohort. Furthermore, DiaCardia maintained substantial predictive ability (AUROC: 0.789) after adjustment for six major confounders using propensity score matching. Higher R-wave amplitude in leads aVL and I, and smaller peak interval dispersion were prominent predictors. Notably, a version of DiaCardia using only single-lead (lead I) ECG data achieved a comparable AUROC of 0.844 (sensitivity: 82.3%; specificity: 70.2%).

conclusionsThis study establishes that an AI model, DiaCardia, can accurately identify individuals with prediabetes from an ECG alone, with performance that is robust across different patient cohorts and independent of major clinical confounders. Our highly generalizable, single-lead DiaCardia model offers a promising solution for scalable prediabetes screening via wearable devices, potentially enabling early, home-based detection and transforming diabetes prevention strategies.

Indexed as

Artificial IntelligenceElectrocardiographyHeart RatePrediabetic StateAdultAgedBiomarkersBlood GlucoseDatabases, FactualEarly DiagnosisFemaleGlycated HemoglobinHumansMaleMiddle AgedPredictive Value of TestsBiomarkersBlood GlucoseGlycated Hemoglobinhemoglobin A1c protein, humanArtificial intelligenceElectrocardiogramMachine learningPrediabetes

Identifiers

PMID41214697
PMCPMC12604153

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.